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Number of Surgically Removed Mediastinal Lymph-Nodes 
(SRMLNs) as prognostic factor for survival in resected early stage 
non-small-cell lung cancer (NSCLC): a retrospective analysis of a 
mono-institutional series
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Background: The impact on outcome provided by the extent of lym-
phoadenectomy in patients undergoing lobectomy or pneumonectomy 
for early stage (I-IIIA) NSCLC is still controversial. Several reports 
have documented a non signiﬁcant effect of such procedure on both 
disease-free and overall-survival (DFS/OS). Nevertheless, especially 
in trials of adjuvant chemotherapy, a very wide range of nodes number 
across all series is reported, strongly suggesting a clariﬁcation about the 
eventual supposed prognostic role of this intervention.
Methods: A retrospective series of resected NSCLC patients was 
retrieved from the ﬁles of the Regina Elena National Cancer Institute. 
Correlation between known prognostic factors (sex, type of surgery, 
histology, tumor size, node involvement, grading) plus the number of 
SRMLNs and clinical outcome (DFS and OS) was then retrospectively 
explored using both the Cox regression model (considering SRMLNs 
as quantitative variable; signiﬁcance cut-off<0.10) as well as classiﬁca-
tion and regression trees (CART) analysis.
Results: Data referring to 122 NSCLC patients who underwent surgery 
for stage I-IIIA NSCLC were collected. Multivariate analysis identiﬁed 
SRMLNs as signiﬁcant independent predictors of both DFS and OS, 
with an hazard ratio of 0.94 (95% CI 0.90, 0.97, p=0.003), and 0.94 
(95% CI 0.90, 0.99, p=0.035), respectively, together with nodal in-
volvement, and grading G3. The CART analysis identiﬁed 26 removed 
nodes as the cut-off for better outcome. When considering SRMLNs 
as categorical variable, patients with more than 26 removed nodes had 
a signiﬁcant better DFS and OS, with an hazard ratio of 3.90 (95% CI 
1.16, 13.09, p=0.027), and 4.01 (95% CI 0.93, 18.18, p=0.063), respec-
tively, at the multivariate analysis.
Conclusions: Data presented herein open the issue that prognosis of 
early stage of NSCLC can be inﬂuenced by the extent of mediastinal 
lymphoadenectomy. Further prospective analyses are needed to conﬁrm 
this ﬁnding.
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Surgery in patients with lung cancer aged 80 years or more. Age 
matters?
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Background: More people now live longer and healthier lives, and 
consequently more patients in high ages with potentially operable lung 
tumours are seen. The aim of the present investigation was to evaluate 
survival after surgery in those patients.
Material: All patients aged 80 years or above who had surgery for 
lung cancer from 1991 to 2005 at the Karolinska University Hospital 
Sweden were retrospectively reviewed.
Results: There were 49 patients, 16 women and 33 men. The mean 
age was 81.6 years and the oldest patient was 87 years. Fifteen were 
current smokers, 24 ex-smokers, 9 had never smoked and data was 
missing in one. Their PS was 0-1. Preoperative diagnosis was available 
in 14 cases. The upper lobe was removed in 21 patients (right 11, left 
10), the lower lobe in 19 (right 10 and left 9), middle lobe in 2, both 
middle and upper lobe also in 2, and pulmectomy in 5 patients (2 right 
and 3 left). Two patients had to be reoperated acutely, both because of 
haemorrhage intrathoracically. There was no peroperative mortality. 
Of the patients who had a pulmectomy, two died within 3 months, both 
due to metastases. The other lived approximately 6, 12 and 25 months 
respectively. Of those 19 operated the ﬁrst 5 years, 4 are still alive. The 
longest survivor was operated with right upper lobectomy at age 81 in 
1993. Of 36 operated before February 2002, 17 patients survived more 
than 5 years. In all, 18 patients are still alive. 
Conclusion: Thoracic surgery in patients aged 80 years or more is 
feasible if they have a good PS and long-term survival can be expected 
in a signiﬁcant number. Peroperative morbidity and mortality are low. 
With better staging methods such as PET, results can probably be 
improved. An alternative to surgery is precision radiotherapy but com-
parative studies are missing.
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Objective: The aim of the current study is to collect and compile fac-
tors that could inﬂuence the survival of patients who have undergone 
surgical treatment for bronchial carcinoids. 
Background: Bronchial carcinoids account for 0.5-5% of all lung 
tumours according to different sources from literature. In Sweden there 
is an incidence of 0.7 / 100 000 corresponding to 60-70 new cases 
every year. Of these 90 % can be classiﬁed as typical carcinoids (TC). 
TC is a low malignant tumour with a ﬁve year survival rate of 87-100 
%. The atypical carcinoid (AC) shows a more aggressive behaviour 
with high mortality rate and a strong tendency to produce metastases. It 
has not come to a consensus whether pulmonary carcinoids should be 
operated with an anatomical resection or if parenchymal saving surgery 
is enough. It is also a matter of debate if a radical lymphadenectomy is 
indicated by patients with pulmonary carcinoids. 
Methods: Data were collected retrospectively from 1097 patients who 
underwent surgical treatment on the indication suspected or proven 
bronchial malignancy at Huddinge University Hospital Stockholm, 
Sweden, from the start of the departement 1992 to the fusion with 
Karolinska Hospital 2004. From this base we identiﬁed all bronchial 
carcinoids being operated. All tumours were then classiﬁed according 
to the 1999 WHO classiﬁcation. All patients were included in a routine 
follow up program, which included x-ray of the lungs and physical 
examination every 12 month. Cumulative survival was estimated by the 
Kaplan Meier method. Differences in survival were tested for sub-
groups using log rank test. 
Results: There were 39 patients with bronchial carcinoids, constitut-
ing 6 % of all operated and diagnosed lung tumours. Of these 20 were 
males and 19 females. Thirtyone of the 39 patients were classiﬁed 
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with TC and eight with AC. Smokers and men had a shorter survival 
compared with non-smokers and women. Of patients with AC 75 % 
smoked and with TC 52 %. Patients with AC had a higher mean age 
(67.9 years) than patient with TC (57.6 years). Five patients developed 
distant metastases, all with AC. The median survival for both TC and 
AC together was 156 months. Median survival for patients with AC 
was 132 months. 
Conclusion: Smoking has a negative effect on survival in pulmonary 
carcinoids. Mean age is higher in patients with AC. This indicates that 
younger non smoking patients should as a rule be subjects for a paren-
chymal saving operation while anatomical resection should more often 
be considered in older smoking patients. However, very large materials 
are needed to study bronchial carcinoids because it is a rare entity.
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Caspase-3 and c-myc expression in completely resected non-small 
cell lung cancer and its prognostic significance.
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Background: An imbalance between apoptosis and proliferation is 
believed to underlie tumor development and prognosis. The present 
study focuses on two molecules playing important roles in the cellular 
pathways affecting apoptosis. Caspase-3 is a cysteine protease that 
plays a major role in the process of apoptotic cell death and dysregulat-
ed expression of c-myc contributes to the tumorigenesis of a variety of 
human cancers. The aim of this study was to investigate the expression 
of caspase-3 and c-myc and their signiﬁcances as prognosis marker in 
completely resected non-small cell lung carcinomas (NSCLC). 
Methods: A total 130 consecutive patients who had undergone com-
plete resection without pre-operative radio- or chemotherapy between 
May 1996 and December 2003 for NSCLC were retrospectively 
reviewed. The median follow-up period of the patients was 50 months 
(range, 3-128 months). The expressions of caspase-3 and c-myc were 
immunohistochemically examined, and correlated with the clinico-
pathologic data. 
Results: There were 99 men and 31 women with, a median age of 62 
years (range, 34 ~ 78). The T status distribution was as follows: T1 36, 
(28%), T2, 80 (61%), and T3, 14 (11%). There are 82 (63%) patients in 
N0, 20 (15%) in N1, and 28 (22%) in N2. All patients were pathologi-
cally staged according to AJCC guidelines: 27 patients in stage Ia, 48 in 
Ib, 5 in IIa, 21 in IIb, and 29 in IIIa. Histologically, 63 were squamous 
cell carcinoma, 46 adenocacinoma, and 21 large cell carcinoma and 
others. The prevalence of caspase-3 and c-myc expression in patients 
is 68% (88/130) and 59% (77/130), respectively. Signiﬁcant associa-
tion was found between caspase-3 and c-myc expressions (p=0.035). A 
signiﬁcant correlation was observed between the expression of c-myc 
and lymphatic invasion of tumor tissues (p=0.001). Caspase-3 and 
c-myc expression was not signiﬁcantly associated with prognosis in 
total patients of completely resected NSCLC. However, according to 
stages, caspase-3 expression was signiﬁcantly correlated with favorable 
prognosis in stage IIIa (p=0.021). A multivariate analysis showed the 
pathologic stage to be signiﬁcantly correlated with good prognosis in 
total patients (p=0.024), and caspase-3 expression and tumor differen-
tiation in stage IIIa patients (p=0.005, p=0.003, respectively). 
Conclusions: Caspase-3 expression using immunohistochemical stain-
ing may be a favorable prognostic indicator in completely resected 
NSCLC of advanced stage. 
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Prognosis after surgical resection of intralobar satellite T4 NSCLC: 
Is it relevant to designate as T4?
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Background: It is controversial that intralobar satellites are designated 
as T4 disease in current staging system of non-small cell lung cancer. 
We sought to determine the impact of intralobar satellite tumors on 
patient survival and its potential relevance to stage IIIB.
Methods: Retrospective review of our lung cancer registry was con-
ducted from 1995 to 2004. Complete preoperative workup and routine 
mediastinoscopy were performed. Fifty seven patients with pathologi-
cally-proven T4 by satellite tumor nodules were included. Cases with 
multifocal bronchioloalveolar cancer, neoadjuvant therapy or operative 
mortality were excluded. All patients had curative resection and medi-
astinal lymph node dissection. Satellites were detected preoperatively 
(n = 9) or in the resected specimen (n = 48). Median follow-up for the 
entire group was 29 months. Survival was calculated by the Kaplan-
Meier method. A Cox proportional hazards model was performed to 
examine the effects on overall survival of age, gender, nodal disease, 
number of satellite lesions, cell types, and original T status disregarding 
staellites.
Results: The median age of the 57 patients with intralobar satellites 
was 65 years and 14 were women. Four patients had more than one 
satellite lesion. Overall 5-year survival was 39.1% for all patients with 
resected intralobar satellites. Patients without(n=31) nodal metastases 
had a better 5-year survival of 43.0% than those with(n=26) nodal dis-
eases (N1 or N2) of 34.6% (p value 0.022). A Cox proportional hazards 
model also showed that nodal status had the only statistical signiﬁcance 
(p value 0.024).
Conclusions: Patients with intralobar satellite NSCLC have a relatively 
favorable prognosis after surgical resection. Especially satellites in 
T4N0 patients deserve to be designated as earlier stages of NSCLC.
